SPARC-1613
- Generic Name
- SPARC-1613
Pharmacokinetic Study of SPARC1613 and reference1613 in Subjects With Locally Recurrent or Metastatic Breast Cancer
Phase 1
Completed
- Conditions
- Recurrent or Metastatic Breast Cancer
- Interventions
- Drug: Reference1613
- First Posted Date
- 2017-04-12
- Last Posted Date
- 2019-05-03
- Lead Sponsor
- Sun Pharma Advanced Research Company Limited
- Target Recruit Count
- 142
- Registration Number
- NCT03109249
- Locations
- 🇮🇳
SPARC Site 4, Pune, Maharashtra, India
🇮🇳SPARC Site 15, Khorda, Orissa, India
🇮🇳SPARC Site 9, Aurangabad, Marashtra, India
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath